FCF Biotech Venture Capital Monitor – USA 12/2022 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 12/2022”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As
FCF European Infrastructure & Construction Market Study 2022 – published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF European Infrastructure & Construction Market Study – 2022”. Based on available data from European infrastructure and construction companies, the FCF Infrastructure & Construction
FCF – Sponsor of the 7th ECP on February 23-24, 2023 in Düsseldorf, Germany
From February 23 to February 24, 2023, the ECP – European Chemistry Partnering Congress, the business speed dating event for the chemical and biotech industry, will take place for the seventh time in Düsseldorf, Germany.
FCF Valuation Monitor – Q4 2022 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Valuation Monitor – Q4 2022”. The FCF Valuation Monitor is a comprehensive valuation analysis for the German small / midcap market segment and
Life Sciences Venture Capital Monitor – Europe 12/2022 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 12/2022”. The Monitor is a monthly published overview of venture capital trends in the European Life Sciences
FCF Bank Monitor – Q4 2022 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Bank Monitor – Q3 2022”. FCF regularly engages in research on the banking sector based on available data from the most active and
FCF Fox Corporate Finance GmbH advised German Bionic on a venture debt financing
FCF Fox Corporate Finance GmbH advised German Bionic on a venture debt financing Munich, January 24, 2023 – The European Investment Bank (EIB) has invested EUR 15 million in the form of a venture debt
FCF Biotech Venture Capital Monitor – USA 11/2022 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 11/2022”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As
FCF TMT Market Study 2022 – published
FCF Fox Corporate Finance GmbH is pleased to publish the new “FCF TMT Market Study – 12/2022”. Based on available data from European TMT (Technology, Media & Telecommunications) companies, the FCF TMT MARKET STUDY is
Life Sciences Venture Capital Monitor – Europe 11/2022 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 11/2022”. The Monitor is a monthly published overview of venture capital trends in the European Life Sciences
